Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
New England Journal of Medicine · 16.07.2026 · 395 (3) · 243-254
DOI: 10.1056/nejmoa2516150 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 16.07.2026. Verfasst von Richard A Furie und 25 weiteren Autor:innen. Beteiligte Einrichtung: Northwell, New Hyde Park, NY. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: F. Hoffmann-La Roche Ltd..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Northwell, New Hyde Park, NY.
- Division of Rheumatology, Northwell, Great Neck, NY.
- University of California, San Francisco, San Francisco.
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
- National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
- Genentech, South San Francisco, CA.
Förderung
- F. Hoffmann-La Roche Ltd.
Zitieren
APA
Furie, R. A., Dall'Era, M., Vital, E. M., Garg, J. P., Irazoque Palazuelos, F., Zuta Santillán, A. E., Ravelo-Hernández, J., Santiago, M. B., Zazueta Montiel, B., Botha, S., Leszczyński, P., de Souza, V. A., Sicsik, S. A., Bellatin, L., Naidoo, A., Amoura, Z., D'Agostino, M. A., Kumar, S., Workeneh, B., …, & ALLEGORY Trial Investigators (2026). Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus. New England Journal of Medicine, 395(3), 243-254. https://doi.org/10.1056/nejmoa2516150
Vancouver
Furie RA, Dall'Era M, Vital EM, Garg JP, Irazoque Palazuelos F, Zuta Santillán AE, et al. Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus. New England Journal of Medicine. 2026;395(3):243-254. doi:10.1056/nejmoa2516150
BibTeX
@article{Furie2026,
author = {Furie, Richard A and Dall'Era, Maria and Vital, Edward M and Garg, Jay P and Irazoque Palazuelos, Fedra and Zuta Santillán, Adolfina E and Ravelo-Hernández, Jorge and Santiago, Mittermayer B and Zazueta Montiel, Beatriz and Botha, Stella and Leszczyński, Piotr and de Souza, Viviane Angelina and Sicsik, Sandra A and Bellatin, Luis and Naidoo, Asokan and Amoura, Zahir and D'Agostino, Maria Antonietta and Kumar, Sunil and Workeneh, Biruh and Rae, Julie and Mao, Huiyan A and Erblang, Felix and Meier, Oliver and Maller, Justine C and Askanase, Anca D and ALLEGORY Trial Investigators, ALLEGORY Trial Investigators},
title = {Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {3},
pages = {243--254},
doi = {10.1056/nejmoa2516150}
}
EUVIMED